Product Data Sheet

NBI-35965

Catalog No. A59766

main product photo
NBI-35965 is a selective antagonist of corticotropin-releasing factor receptor 1 (CRF-R1). This compound is utilized in research applications focusing on the nervous system, particularly in studies exploring stress response, anxiety, and depression. By inhibiting CRF-R1 activity, NBI-35965 provides valuable insights into the mechanisms underlying these neuropsychiatric disorders.
Chemical Information
Catalog NumA59766
M. Wt401.33
FormulaC21H22Cl2N4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.268546-19-6
Synonyms
SMILESCC[C@H]1CN2N=C(C3=C(C=C(C=C3)Cl)Cl)C4=NC(C)=CC(N1CC5CC5)=C42
Biological Activity
DescriptionNBI-35965 is a selective antagonist of corticotropin-releasing factor receptor 1 (CRF-R1). This compound is utilized in research applications focusing on the nervous system, particularly in studies exploring stress response, anxiety, and depression. By inhibiting CRF-R1 activity, NBI-35965 provides valuable insights into the mechanisms underlying these neuropsychiatric disorders.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.